Add Yahoo as a preferred source to see more of our stories on Google. Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped ...
There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...
Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden's Cancer Moonshot initiative had funded hundreds of cancer research projects across the country. AP Photo/Gerald Herbert ...
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...
I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.
CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.
If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...
Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
This is an opinion column. I handed the sheet of paper to my wife. It was filled with words, necessary and important words. I couldn’t see them, though — or, couldn’t see them. “Brief Summary of ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.